FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.52, in-line with the analyst estimate of $0.52. Revenue for the quarter came in at $255.7 million versus the consensus estimate of $257.27 million.
GUIDANCE:
Integra LifeSciences sees FY2017 EPS of $1.88-$1.94, versus the consensus of $1.93.... More

